Wayfinder Biosciences Analysis: $7M Raised
What is Wayfinder Biosciences?
RNA-targeting small molecules for undruggable targets
Location
Seattle, United States
Employees
11-50
Founded
2021
Product Features & Capabilities
- RNA-targeting small molecules that bind to mRNA
- Proprietary RNA-based sensors for drug discovery
- AI/ML screening for selective small molecules
- Scalable platform for quantitative insights
- Therapeutics targeting oncology and neurodegeneration.
Use Cases
Neutralize toxic effects of disease genes; Prevent production of harmful proteins; Develop therapeutics for oncology; Target undruggable disease areas; Collaborate on neurodegeneration programs.
